Faes Farma and Pfizer Are Negotiating Semi Exclusive Licences for Bilastine in Certain Countries
BILBAO, Spain, June 22, 2009--Faes Farma is still in conversations with high level partners (Pfizer is the world leader) in order to complete the co-marketing agreements in Europe and in the big emergent markets.
Once the Registration Dossier has been submitted to the EMEA, our company´s efforts are concentrated in completing, during the next months, the negotiation processes opened in South America and Africa, and for second brands in the big European markets.
Posted: June 2009
Recommended for you